To Evaluate Effect of Food of DA-5222 in Healthy Adult Subjects

Launched by DONG-A ST CO., LTD. · May 19, 2025

Keywords

ClinConnect Summary

This clinical trial is designed to study how food affects the way the body processes a medication called DA-5222 in healthy adults. Researchers want to understand if eating has any impact on how this drug works. This study is still in the planning stages and hasn’t started recruiting participants yet.

To participate, you need to be a healthy adult between the ages of 18 and 39, with a body mass index (BMI) between 18 and 30. This means your weight is in a healthy range for your height. Participants must also weigh at least 50 kg (about 110 pounds) for men and 45 kg (about 99 pounds) for women. You’ll need to sign a consent form, which means you agree to join the study after learning about it in detail. However, individuals with serious health issues, a history of drug addiction, or allergies to medications cannot take part in this trial. If you join, you’ll help researchers gather important information that could help improve treatment options in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Healthy volunteers
• • BMI between 18 and 30 kg/m2
• • Body weight: Male≥50kg, Female≥45kg
• • Subjects who have signed an informed consent themselves after receiving detailed explanation about clinical study
• Exclusion Criteria:
• • Subjects with clinically significant medical history
• • Subjects with history of drug abuse or addicted
• • Subjects with allergy or drug hypersensitivity